title: Prostaglandin E1 therapy in orthotopic liver transplantation recipients: indications and outcome.
authors.affiliation: National Liver Transplant Unit, Austin Hospital, Heidelberg, Victoria.
authors.forename: S
authors.initials: S
authors.lastname: Tancharoen
authors.forename: R M
authors.initials: RM
authors.lastname: Jones
authors.forename: P W
authors.initials: PW
authors.lastname: Angus
authors.forename: I D
authors.initials: ID
authors.lastname: Michell
authors.forename: L
authors.initials: L
authors.lastname: McNicol
authors.forename: K J
authors.initials: KJ
authors.lastname: Hardy
mesh_terms: D000328:Adult; D000527:Alprostadil / Q000008:administration & dosage / Q000627:therapeutic use*; D002648:Child; D002675:Child, Preschool; D005260:Female; D006084:Graft Rejection / Q000188:drug therapy / Q000517:prevention & control*; D006801:Humans; D007262:Infusions, Intravenous; D008111:Liver Function Tests; D016031:Liver Transplantation / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged
chemical_list: D000527:Alprostadil; D008775:Methylprednisolone